BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11095135)

  • 1. Platinum-based chemotherapy with or without thoracic radiation therapy in patients with unresectable thymic carcinoma.
    Nakamura Y; Kunitoh H; Kubota K; Sekine I; Shinkai T; Tamura T; Kodama T; Sumi M; Kohno S; Saijo N
    Jpn J Clin Oncol; 2000 Sep; 30(9):385-8. PubMed ID: 11095135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy with doxorubicin, vincristine, cyclophosphamide, and platinum compounds for advanced thymic carcinoma.
    Agatsuma T; Koizumi T; Kanda S; Ito M; Urushihata K; Yamamoto H; Hanaoka M; Kubo K
    J Thorac Oncol; 2011 Dec; 6(12):2130-4. PubMed ID: 21892103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of radiotherapy for thymic carcinoma.
    Nonaka T; Tamaki Y; Higuchi K; Katoh H; Nakahashi M; Horikoshi H; Takahashi K; Minato K; Sugihara S; Kojima M
    Jpn J Clin Oncol; 2004 Dec; 34(12):722-6. PubMed ID: 15640502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin and irinotecan combination chemotherapy for advanced thymic carcinoma: evaluation of efficacy and toxicity.
    Okuma Y; Hosomi Y; Takagi Y; Iguchi M; Okamura T; Shibuya M
    Lung Cancer; 2011 Dec; 74(3):492-6. PubMed ID: 21665316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma.
    Yoh K; Goto K; Ishii G; Niho S; Ohmatsu H; Kubota K; Kakinuma R; Nagai K; Suga M; Nishiwaki Y
    Cancer; 2003 Sep; 98(5):926-31. PubMed ID: 12942558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Prospective Phase II Study of Cisplatin and Cremophor EL-Free Paclitaxel (Genexol-PM) in Patients with Unresectable Thymic Epithelial Tumors.
    Kim HS; Lee JY; Lim SH; Sun JM; Lee SH; Ahn JS; Park K; Moon SH; Ahn MJ
    J Thorac Oncol; 2015 Dec; 10(12):1800-6. PubMed ID: 26484631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy for advanced thymic carcinoma: clinical response to cisplatin, doxorubicin, vincristine, and cyclophosphamide (ADOC chemotherapy).
    Koizumi T; Takabayashi Y; Yamagishi S; Tsushima K; Takamizawa A; Tsukadaira A; Yamamoto H; Yamazaki Y; Yamaguchi S; Fujimoto K; Kubo K; Hirose Y; Hirayama J; Saegusa H
    Am J Clin Oncol; 2002 Jun; 25(3):266-8. PubMed ID: 12040285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage chemotherapy with carboplatin and paclitaxel for cisplatin-resistant thymic carcinoma--three cases.
    Komatsu Y; Koizumi T; Tanabe T; Hatayama O; Yasuo M; Okada M; Yamamoto H; Kubo K; Sasabayashi M; Tsunoda T
    Anticancer Res; 2006; 26(6C):4851-5. PubMed ID: 17214351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of thymic carcinoma responded to intra-arterial chemotherapy combined with radiation therapy].
    Yamamoto A; Imai S; Gyoten M; Kajihara Y
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):1967-70. PubMed ID: 12465397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of thymic carcinoma successfully controlled by combined chemotherapy and irradiation].
    Beppu H; Nodera H; Atarashi K; Yoshimura N; Tsukimoto K; Nagashima Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Jun; 33(6):635-9. PubMed ID: 7666619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of metastatic thymic carcinoma with cisplatin, vinblastine, bleomycin, and etoposide chemotherapy.
    Carlson RW; Dorfman RF; Sikic BI
    Cancer; 1990 Nov; 66(10):2092-4. PubMed ID: 1699650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to sorafenib in cisplatin-resistant thymic carcinoma: a case report.
    Li XF; Chen Q; Huang WX; Ye YB
    Med Oncol; 2009; 26(2):157-60. PubMed ID: 18846437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thymic carcinoma effectively treated by preoperative concurrent chemo-radiotherapy].
    Akiyama Y; Saito S; Kimura S; Shirono R; Fujii Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Sep; 34(9):1030-4. PubMed ID: 8937150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel and cisplatin with concurrent radiotherapy followed by surgery in locally advanced thymic carcinoma.
    Fukuda M; Obase Y; Miyashita N; Kobashi Y; Mohri K; Ueno S; Hayama M; Shimizu K; Nishimura H; Nakata M; Oka M
    Anticancer Res; 2007; 27(3B):1601-4. PubMed ID: 17595782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key components of chemotherapy for thymic malignancies: a systematic review and pooled analysis for anthracycline-, carboplatin- or cisplatin-based chemotherapy.
    Okuma Y; Saito M; Hosomi Y; Sakuyama T; Okamura T
    J Cancer Res Clin Oncol; 2015 Feb; 141(2):323-31. PubMed ID: 25146529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amrubicin as second-line and beyond treatment for platinum-refractory advanced thymic carcinoma.
    Hirai F; Seto T; Yamanaka T; Toyozawa R; Inamasu E; Kojo M; Toyokawa G; Morodomi Y; Shiraishi Y; Takenaka T; Yamaguchi M; Takenoyama M; Ichinose Y
    Jpn J Clin Oncol; 2013 Oct; 43(10):1018-22. PubMed ID: 23917962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced stage thymomas and thymic carcinomas: results of multimodality treatments.
    Lucchi M; Ambrogi MC; Duranti L; Basolo F; Fontanini G; Angeletti CA; Mussi A
    Ann Thorac Surg; 2005 Jun; 79(6):1840-4. PubMed ID: 15919267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive chemotherapy with cisplatin, doxorubicin, cyclophosphamide, etoposide and granulocyte colony-stimulating factor for advanced thymoma or thymic cancer: preliminary results.
    Oshita F; Kasai T; Kurata T; Fukuda M; Yamamoto N; Ohe Y; Tamura T; Eguchi K; Shinkai T; Saijo N
    Jpn J Clin Oncol; 1995 Oct; 25(5):208-12. PubMed ID: 7474409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-line chemotherapy of platinum compound plus CPT-11 following ADOC chemotherapy in advanced thymic carcinoma: analysis of seven cases.
    Kanda S; Koizumi T; Komatsu Y; Yoshikawa S; Okada M; Hatayama O; Yasuo M; Tsushima K; Urushihata K; Kubo K; Sasabayashi M; Takamizawa A
    Anticancer Res; 2007; 27(4C):3005-8. PubMed ID: 17695487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical non-squamous carcinoma: an effective combination chemotherapy of taxane, anthracycline and platinum for advanced or recurrent cases.
    Kimura T; Miyatake T; Ueda Y; Ohta Y; Enomoto T; Kimura T; Kamiura S
    Eur J Obstet Gynecol Reprod Biol; 2012 Oct; 164(2):200-4. PubMed ID: 22770633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.